SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Ionis Pharmaceuticals (IONS)
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
4676 121 0 IONS
Emcee:  Keith Fauci Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
4226Isis Pharmaceuticals "overweight," target price raised Tuesday, Octobbob zagorin-10/10/2007
4225Isis Receives $1.25 Million Milestone Payment From iCo for Initiation of Phase 1bob zagorin-10/9/2007
4224Isis Favorably Revises Financial Guidance and Introduces Mipomersen as Generic Nbob zagorin-10/8/2007
4223Isis Reports Preclinical Data Supporting Liver Safety of ISIS 301012 Saturday Ocbob zagorin-10/7/2007
4222Isis Reports That ISIS 301012 is Well Tolerated in Patients Treated for Five Or bob zagorin-10/5/2007
4221Jeffries target raised to $20 from $17 Isis Pharmaceuticals-ISIS target raised bob zagorin-10/5/2007
4220link to tables and formal presentation data S & A of ISIS 301012 in HeFH fbob zagorin-10/4/2007
4219>>Isis Reports Positive Results of Phase 2 Study of ISIS 301012 in Heteroztuck-10/4/2007
4218updated data for DALM. (includes tables) biz.yahoo.combob zagorin-10/4/2007
4217Biotech, Antisense, RNAi RNAi Firms Find a New Rival (and Partner) in an Old Tecbob zagorin-10/4/2007
4216Isis Awarded $1.5 Million NIH Grant to Improve Chemical Properties of RNAi-Basedbob zagorin-10/3/2007
4215The Next Next Big Thing “Major pharma decision-makers expressed optimism on thebob zagorin-10/3/2007
4214isis at a 5 yr high. the antitrust clearance on the J&J deal today is worth bob zagorin-10/2/2007
4213Isis Announces HSR Approval and Closure of Its Collaboration With Ortho-McNeil, bob zagorin-10/2/2007
4212Isis Earns $5 Million Milestone Payment From Ortho-McNeil, Inc. for Initiation obob zagorin-10/2/2007
4211Webcast Alert: Isis Pharmaceuticals Discusses its New ISIS 301012 Phase 2 Clinicbob zagorin-10/1/2007
4210>>Isis Acquires Symphony GenIsis Thursday September 27, 4:09 pm ET ISIS 30tuck-9/27/2007
4209Jeffries note re DALM : Isis Pharmaceuticals-ISIS expect positive phase 2 data bob zagorin-9/27/2007
4208Isis Announces $1.2 Million Award to Its Ibis Subsidiary to Expand Influenza Detbob zagorin-9/26/2007
4207Oral delivery of antisense oligonucleotides in man Lloyd G. Tillman *, Richard Sbob zagorin-9/25/2007
4206more detail.. Isis Pharmaceuticals-ISIS target raised to $18 from $14, reiteratbob zagorin-9/24/2007
4205ag edwards reiterates buy raises target to 18 Coverage Reit/Price Tgt Changed* bob zagorin-9/24/2007
4204The long term Call options (leaps) are reflecting this. A little sell off todayMJ-9/20/2007
4203Big Potential for ISIS Technology Big Potential for ISIS Technology Thursday Sebob zagorin-9/20/2007
4202i made $$$ on alny but sold way too early.... ditto for sgmo...bob zagorin-9/19/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News